105 related articles for article (PubMed ID: 12893220)
1. A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values.
Mikami M; Suzuki A; Takehara K; Komiyama S; Ishikawa M; Hirose T
Gynecol Oncol; 2003 Aug; 90(2):462-5. PubMed ID: 12893220
[TBL] [Abstract][Full Text] [Related]
2. Solitary splenic metastasis of an adenocarcinoma of the ovaries.
Max LD; Stastny JF; Frable WJ
Gynecol Obstet Invest; 1996; 42(3):214-6. PubMed ID: 8938479
[TBL] [Abstract][Full Text] [Related]
3. Solitary splenic metastasis of ovarian cancer.
Furukawa N
Arch Gynecol Obstet; 2007 Jun; 275(6):499-502. PubMed ID: 17096159
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer.
Otrock ZK; Seoud MA; Khalifeh MJ; Makarem JA; Shamseddine AI
Int J Gynecol Cancer; 2006; 16(5):1933-5. PubMed ID: 17009994
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
[TBL] [Abstract][Full Text] [Related]
6. The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer.
Fayed ST; Ahmad SM; Kassim SK; Khalifa A
Dis Markers; 1998 Nov; 14(3):155-60. PubMed ID: 10427474
[TBL] [Abstract][Full Text] [Related]
7. Does Human Epididymis Protein 4 (HE4) Have a Role in Prediction of Recurrent Epithelial Ovarian Cancer.
Innao P; Pothisuwan M; Pengsa P
Asian Pac J Cancer Prev; 2016; 17(9):4483-4486. PubMed ID: 27797265
[TBL] [Abstract][Full Text] [Related]
8. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
[TBL] [Abstract][Full Text] [Related]
9. Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries.
Mariampillai AI; Cruz JPD; Suh J; Sivapiragasam A; Nevins K; Hindenburg AA
Anticancer Res; 2017 Jul; 37(7):3649-3656. PubMed ID: 28668856
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of combined PET/CT for patient with epithelial ovarian cancer showing recurrence based on tumor marker CA125.
Muramatsu T; Yamashita E; Takahashi K; Sugiyama T; Tsukada H; Kondo A; Hirasawa T; Murakami M; Yasuda S; Mikami M
Tokai J Exp Clin Med; 2007 Mar; 32(1):23-7. PubMed ID: 21319052
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of determining tumor markers CEA, CA125 and CA72-4 in blood serum of patients with ovarian carcinoma].
Kokocińska D; Worwag J; Tomala J; Dzieciuchowicz L; Nowak S; Kuśmierski S
Ginekol Pol; 1994 Sep; 65(9):495-501. PubMed ID: 7721162
[TBL] [Abstract][Full Text] [Related]
12. [A case of solitary splenic metastasis from an ovarian cancer 12 years after primary resection].
Hasegawa H; Naitoh H; Tsuchihashi H; Okada K; Furukawa H; Hanasawa K
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1799-803. PubMed ID: 20841951
[TBL] [Abstract][Full Text] [Related]
13. Increased cathepsin L levels in serum in some patients with ovarian cancer: comparison with CA125 and CA72-4.
Nishida Y; Kohno K; Kawamata T; Morimitsu K; Kuwano M; Miyakawa I
Gynecol Oncol; 1995 Mar; 56(3):357-61. PubMed ID: 7705668
[TBL] [Abstract][Full Text] [Related]
14. Malignant Brenner tumors of the ovary and tumor markers: case reports.
Yamamoto R; Fujita M; Kuwabara M; Sogame M; Ebina Y; Sakuragi N; Kato H; Fujimoto S
Jpn J Clin Oncol; 1999 Jun; 29(6):308-13. PubMed ID: 10418561
[TBL] [Abstract][Full Text] [Related]
15. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
Zhang M; Cheng S; Jin Y; Zhao Y; Wang Y
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188503. PubMed ID: 33421585
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer.
Bian J; Li B; Kou XJ; Liu TZ; Ming L
Asian Pac J Cancer Prev; 2013; 14(11):6241-3. PubMed ID: 24377511
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
19. NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Xin B; Ji KQ; Liu YS; Zhao XD
Reprod Sci; 2021 Mar; 28(3):745-756. PubMed ID: 33125687
[TBL] [Abstract][Full Text] [Related]
20. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
